• Contact Us
  • Classifieds
  • About
  • Home

Pathway

Baptist & Christian News

  • Missouri
    • MBC
    • Churches
    • Institutions & Agencies
    • Policy
    • Disaster Relief
  • National
    • SBC Annual Meeting
    • NAMB
    • SBC
    • Churches
    • Policy
    • Society & Culture
  • Global
    • Missions
    • Multicultural
  • Columnists
    • John Yeats
    • Don Hinkle
    • Pat Lamb
    • Rhonda Rhea
    • Rob Phillips
  • Ethics
    • Life
    • Liberty
    • Family
  • Faith
    • Apologetics
    • Religions
    • Evangelism
    • Missions
    • Bible Study & Devotion

More results...

Governor signs bill boosting cord blood research

August 11, 2005 By The Pathway

Governor signs bill boosting cord blood research

Promise of adult stem cells much greater than embryonic

By Staff

August 9, 2005

JEFFERSON CITY – Promoting a proven form of stem cell research, Gov. Matt Blunt has signed into law Senate Bill 323, which expands existing umbilical cord banks and establishes new ones throughout the state.

“The use of umbilical cord blood in medical research offers an important and powerful alternative to embryonic stem cell research that shows far less promise,” said state Sen. Matt Bartle, R-Lee’s Summit. Bartle, a deacon at First Baptist Church, Raytown, drafted the legislation and advanced it through the Missouri General Assembly.

The new law, which will be in effect Aug. 28, creates eligibility criteria under which the state’s Life Sciences Research Board can award grants to umbilical cord blood banks. Conditions include the ability and experience of a grant applicant and the level of commitment to cord blood bank expansion the applicant is willing to meet after a grant contract expires.

The program is subject to future appropriations by the Legislature.

Bartle is excited about the new law. By signing it, the governor has sent a signal that this type of research is important, the senator said.

“Umbilical cord blood, preserved after a new baby is born, is a non-controversial source of stem cells, which are considered to be the building blocks of life,” Bartle said. “Non-controversial adult stem cells can be used in the treatment of all kinds of diseases including more than 60 different cancers, genetic diseases, blood disorders and immune deficiencies, and more potentially life-saving applications are constantly being developed.”

On July 6, U.S. Rep. Todd Akin, R-Town & Country, toured the St. Louis Cord Blood Bank at Cardinal Glennon Children’s Hospital to review the facility’s work on cord blood research. The St. Louis Cord Blood Bank, founded in 1996 by Donna Wall, is the second-largest independent cord blood bank in the world. Akin, like Bartle, has expressed his support for this type of research.

“My most fervent hope,” Bartle told The St. Louis Post-Dispatch, “is that the momentum that is behind adult stem cell research will basically leave embryonic stem cell research in the rear-view mirror.”

Comments

Trending

  • Third season of ‘The Chosen’ series: entertaining, but controversy grows
  • Four examples of where the New World Translation gets it wrong
  • Missouri House votes to legalize sports gambling
  • Missouri Senate passes ‘SAFE Act,’ aimed to nix gender transition procedures for minors
  • 10 key biblical doctrines denied by Jehovah’s Witnesses

Ethics

Missouri Senate passes ‘SAFE Act,’ aimed to nix gender transition procedures for minors

Benjamin Hawkins

The Missouri Senate passed two bills protecting children and students from harm caused by the LGBTQ+ agenda, March 23. Both bills are now on their way to the state’s House of Representatives for approval.

Proposal from United States health department would roll back conscience rights, ERLC says

Tom Strode

More Ethics Stories

Missouri

MBU’s Master of Social Work program fully accredited by Council on Social Work Education

Missouri Baptist University

The accreditation of MBU’s online master’s program in social work, by the nation’s sole accrediting body for social work programs, is retroactive to the program’s launch in 2020 and is granted through Feb. 2031.

Copyright © 2023 · The Pathway